EDAPEDAP TMS SA

Nasdaq edap-tms.com


$ 6.97 $ -0.21 (-2.96 %)    

Tuesday, 14-May-2024 15:42:57 EDT
QQQ $ 445.88 $ 2.85 (0.64 %)
DIA $ 395.58 $ 1.12 (0.28 %)
SPY $ 523.16 $ 2.39 (0.46 %)
TLT $ 90.86 $ 0.51 (0.56 %)
GLD $ 218.12 $ 1.83 (0.85 %)
$ 6.89
$ 6.95
$ 0.00 x 0
$ 6.99 x 100
$ 6.95 - $ 6.97
$ 3.60 - $ 12.09
61,683
na
255.65M
$ 0.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 edap-announces-final-results-from-the-hifi-study-comparing-outcomes-of-focal-one-hifu-versus-radical-prostatectomy-during-plenary-session-at-the-119th-american-urological-association-annual-meeting

Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-...

 edap-tms-sa-files-for-mixed-shelf-of-up-to-125m

- SEC Filing

 hc-wainwright--co-maintains-buy-on-edap-tms-raises-price-target-to-19

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Edap TMS (NASDAQ:EDAP) with a Buy and raises the price targ...

 edap-tms-q4-eps-015-misses-005-estimate-sales-2130m-beat-1966m-estimate

Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.05) by...

 earnings-scheduled-for-march-27-2024

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

 earnings-outlook-for-edap-tms
Earnings Outlook For Edap TMS
03/26/2024 15:01:15

 edap-announces-fda-breakthrough-device-designation-for-focal-one-in-the-treatment-of-deep-infiltrating-rectal-endometriosis

EDAP TMS SA (NASDAQ:EDAP), the global leader in robotic energy-based therapies, announced today that its Focal One platform has...

 edap-announces-completion-of-enrollment-in-phase-3-study-evaluating-focal-one-hifu-therapy-for-deep-infiltrating-rectal-endometriosis

60 Patients Completed Enrollment in Under 9 MonthsStudy Results Expected in the Second Half of 2024

 edap-announces-preliminary-q4-record-focal-one-system-sales-and-placements-company-reports-preliminary-placement-results-of-twelve-focal-one-systems-inclusive-of-ten-capital-sales

Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital salesLYON, France, January ...

 edap-announces-positive-opinion-for-reimbursement-from-the-french-national-authority-for-health-for-hifu-treatment-of-prostate-cancer

EDAP TMS SA (NASDAQ:EDAP), ("EDAP"), the global leader in robotic energy-based therapies, today announced that the Fren...

 piper-sandler-maintains-overweight-on-edap-tms-lowers-price-target-to-9-report-released-on-9th-nov-2023

Piper Sandler analyst Jason Bednar maintains Edap TMS (NASDAQ:EDAP) with a Overweight and lowers the price target from $14 t...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 edap-tms-q3-eps-011-inline-sales-1269m-miss-1621m-estimate

Edap TMS (NASDAQ:EDAP) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. The company re...

 recap-edap-tms-q3-earnings
Recap: Edap TMS Q3 Earnings
11/09/2023 11:10:10

Core News & Articles

Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmente...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 283 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 179 companies reached new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION